Natera, Inc. (NTRA) Financials
NTRA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.5 billion | 691.8 million |
2023-09-30 | 1.4 billion | 661.9 million |
2023-06-30 | 1.2 billion | 651.7 million |
2023-03-31 | 1.3 billion | 668.3 million |
NTRA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -67.7 million | 48.9 million |
2023-09-30 | -38.7 million | 57.7 million |
2023-06-30 | -87.4 million | 44.5 million |
2023-03-31 | -92.5 million | 40.7 million |
NTRA Net Income
No data available :(
NTRA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 879.0 million | - | 78.6 million |
2023-09-30 | 936.6 million | - | 68.3 million |
2023-06-30 | 735.9 million | 282.3 million | 71.1 million |
2023-03-31 | 812.0 million | 282.0 million | 73.9 million |
NTRA Shares Outstanding
NTRA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 9.5 million | 83.0 million | 161.4 million | - |
2023-09-30 | 9.1 million | 77.2 million | 154.7 million | - |
2023-06-30 | 9.0 million | 78.2 million | 152.5 million | - |
2023-03-31 | 11.6 million | 82.3 million | 149.6 million | - |
NTRA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 311.1 million | 151.2 million |
2023-09-30 | 268.3 million | 147.3 million |
2023-06-30 | 261.4 million | 143.1 million |
2023-03-31 | 241.8 million | 148.1 million |
NTRA
Price: $96.98
52 week price:
Earnings Per Share: -3.78 USD
P/E Ratio: -15.59
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 659200
Ebitda: -23.3 millionMarket Capitalization: 11.4 billion